Andrew J. Roth

October 06, 2016

Last night's "In Our Genes: An Evening of Storytelling" was an event that not only raised money for research in BRCA-related cancers, but also aimed to raise the spirits of individuals who have been affected by the gene mutation.

September 29, 2016

CURE spoke with an expert on the future of treating triple-negative breast cancer, including the potential for immunotherapy, targeted therapy and AR-targeted agents.

September 28, 2016

Anti-androgen therapies may eventually be used to treat some patients with breast cancer, according to Tiffany A. Traina, M.D.

September 27, 2016

Optimizing treatment for patients with HR-positive breast cancer means that researchers must first find a way for patients to overcome drug resistance, says William J. Gradishar, M.D.

September 16, 2016

Educate, engage and energize — those are the three main verbs and goals of the Bladder Cancer Advocacy Network’s (BCAN) first ever leadership summit.

September 13, 2016

Morris Sherman discusses finding second-line treatments for patients with HCC.

September 12, 2016

The incidence of NASH-associated liver cancer is growing, prompting researchers to further investigate this subset of patients.

September 12, 2016

CURE spoke with Ghassan K. Abou-Alfa about the potential of using a vaccinia to treat advanced HCC.

August 23, 2016

Midostaurin is showing promise for some patients with mastocytosis, a rare disorder that is difficult to treat.

August 05, 2016

What can online searches tell about a potential cancer diagnosis? Scientists at Microsoft are interested in finding out.